Interestingly, in cisplatin-resistant ovarian cancer cells, the expression of FDFT1 was found to be increased by sterol regulatory element binding transcription factor 2 (SREBP2) [90]. The gene discussed is SREBF2; the disease is ovarian carcinoma.